99 related articles for article (PubMed ID: 4796640)
1. The effect of the ergoline derivative VUFB-6683 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Experientia; 1973 Oct; 29(10):1262-3. PubMed ID: 4796640
[No Abstract] [Full Text] [Related]
2. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
3. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
4. Effect of D-6-methyl-8-ergoline-I-ylacetamide (Deprenon) on the FSH content of the rat pituitary during the oestrus cycle and pregnancy.
Chlebounová J; Rezábek K; Seda M; Semonský M
Physiol Bohemoslov; 1974; 23(2):113-8. PubMed ID: 4280585
[No Abstract] [Full Text] [Related]
5. Induction of oestrus and ovulation with an ergoline derivative, substance VUFB 6638, an inhibitor of prolaction secretion.
Ausková M; Rezábek K; Zikán V; Semonský M
Physiol Bohemoslov; 1974; 23(5):417-21. PubMed ID: 4278534
[No Abstract] [Full Text] [Related]
6. Inhibition of prolactin by ergoline congeners.
Barfknecht CF; Rusterholz DB
J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226
[No Abstract] [Full Text] [Related]
7. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
Schreiber B; Pribýl T; Rohácová J
Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
[No Abstract] [Full Text] [Related]
8. [Inhibition of lactation in the rat following administration of D-6-methyl-8-ergolin-I-yl-acetic acid-amide tartrate (VUFB-6683)].
Ausková M; Rezábek K; Semonský M
Arzneimittelforschung; 1973 Apr; 23(4):617-8. PubMed ID: 4740246
[No Abstract] [Full Text] [Related]
9. Effect of d-6-methyl-8-ergoline-i-ylacetamide (Deprenon) on the FSH content of the pituitary in castrated female rats.
Rezábek K; Recábek K
Physiol Bohemoslov; 1976; 25(5):407-10. PubMed ID: 136001
[TBL] [Abstract][Full Text] [Related]
10. Diminution of prostate by ergoline derivative VUFB--6638 (Dironyl) in rats.
Ausková M; Rezábek K; Marhan O; Zikán V; Semonský M
Endocrinol Exp; 1979 Sep; 13(3):171-6. PubMed ID: 315868
[TBL] [Abstract][Full Text] [Related]
11. Physiological variations in prolactin content of the mouse pituitary gland examined by disc electrophoresis and bioassay.
Nicholson PM
J Endocrinol; 1970 Aug; 47(4):403-9. PubMed ID: 5459215
[No Abstract] [Full Text] [Related]
12. Ergolines as potential prolactin and mammary tumor inhibitors.
Cassady JM; Floss HG
Lloydia; 1977; 40(1):90-106. PubMed ID: 327183
[No Abstract] [Full Text] [Related]
13. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
14. Influence of nursing on the release of prolactin and GH in mice with high and low incidence of mammary tumors.
Sinha YN; Salocks CB; Lewis UJ; VanderLaan WP
Endocrinology; 1974 Oct; 95(4):947-54. PubMed ID: 4472149
[No Abstract] [Full Text] [Related]
15. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
16. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
[No Abstract] [Full Text] [Related]
17. [Inhibition of lactation by N-(D-6-methyl-8-isoergolin-1-yl)-N',N'-diethylurea (VUFB-6638)].
Ausková M; Rezábek K; Zikán V; Semonský M
Experientia; 1974 Apr; 30(4):393-4. PubMed ID: 4858213
[No Abstract] [Full Text] [Related]
18. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
Lloyd HM; Meares JD; Jacobi J
Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
[No Abstract] [Full Text] [Related]
19. Effect of thyroactive materials upon plasma corticoids, pituitary prolactin, and mammary oxidative phosphorylation of lactating rats.
Sinha YN; Schmidt GH
J Dairy Sci; 1970 Aug; 53(8):1077-82. PubMed ID: 5528365
[No Abstract] [Full Text] [Related]
20. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
